GSK announces phase III results of mepolizumab for eosinophilic COPD September 13, 2017 CenterWatch Staff
Teva’s Trisenox receives Priority Review for promyelocytic leukemia September 13, 2017 CenterWatch Staff
Agreement to modify cell lines to accelerate cancer therapies signed September 13, 2017 CenterWatch Staff